MOLECULAR ALTERATIONS IN IDH-MUTANT ASTROCYTOMA: A MULTI-INSTITUTIONAL RETROSPECTIVE STUDY

被引：0
|
作者：
Lam, Keng [1 ]
Ozkizilkaya, Hanim [2 ]
Milton, Denai [3 ]
Dono, Antonio [4 ]
Kumar, Vinodh [5 ]
Johnson, Jason [6 ]
Esquenazi, Yoshua [4 ]
Patel, Chirag [1 ]
Ballester, Leomar [7 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, Houston, TX USA
[2] Univ Southern Calif Los Angeles, Keck Sch Med, Dept Pathol, Los Angeles, CA USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX USA
[4] Univ Texas Hlth Sci Ctr Houston, Dept Neurosurg, Houston, TX USA
[5] Univ Texas MD Anderson Canc, Dept Neuroradiol, Houston, TX USA
[6] Yale Univ, Sch Med, Dept Radiol & Biomed Imaging, New Haven, CT USA
[7] Univ Texas MD Anderson Canc, Dept Anat Pathol, Houston, TX USA
来源：
NEURO-ONCOLOGY | 2024年 / 26卷
关键词：
D O I：
10.1093/neuonc/noae165.0715
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PATH-16
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Mitotic Index Thresholds Do Not Predict Clinical Outcome for IDH-Mutant Astrocytoma
    Yoda, Rebecca A.
    Marxen, Troy
    Longo, Lauren
    Ene, Chibawanye
    Wirsching, Hans-Georg
    Keene, C. Dirk
    Holland, Eric C.
    Cimino, Patrick J.
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2019, 78 (11): : 1002 - 1010
  • [32] Genomic characterization of IDH-mutant astrocytoma progression to grade 4 in the treatment setting
    Kirsi J. Rautajoki
    Serafiina Jaatinen
    Anja Hartewig
    Aliisa M. Tiihonen
    Matti Annala
    Iida Salonen
    Masi Valkonen
    Vili Simola
    Elisa M. Vuorinen
    Anni Kivinen
    Minna J. Rauhala
    Riikka Nurminen
    Kendra K. Maass
    Sirpa-Liisa Lahtela
    Arja Jukkola
    Olli Yli-Harja
    Pauli Helén
    Kristian W. Pajtler
    Pekka Ruusuvuori
    Joonas Haapasalo
    Wei Zhang
    Hannu Haapasalo
    Matti Nykter
    Acta Neuropathologica Communications, 11
  • [33] CLINICAL AND RADIOGRAPHIC PREDICTORS OF PROGNOSIS IN ASTROCYTOMA, IDH-MUTANT, WHO GRADE 4
    Lasica, Aleksandra B.
    Lan, Zhou
    Miller, Julie J.
    Russ, Alyssa
    Westergaard, Catharina
    Lee, Eudocia Q.
    Chukwueke, Ugonma
    Castro, Luis Nicolas Gonzalez
    Figueroa, Jose Ricardo McFaline
    Aquilanti, Elisa
    Nayak, Lakshmi
    Beroukhim, Rameen
    Batchelor, Tracy
    Nakhate, Vihang
    Lanman, Tyler
    Botero, Juan Pablo Ospina
    Stec, Natalie
    Reardon, David A.
    Wen, Patrick Y.
    Youssef, Gilbert
    NEURO-ONCOLOGY, 2024, 26
  • [34] MITOTIC INDEX THRESHOLDS DO NOT PREDICT CLINICAL OUTCOME FOR IDH-MUTANT ASTROCYTOMA
    Yoda, Rebecca
    Marxen, Troy
    Longo, Lauren
    Ene, Chibawanye
    Wirsching, Hans-Georg
    Keene, Dirk
    Holland, Eric
    Cimino, P. J.
    NEURO-ONCOLOGY, 2019, 21 : 144 - 144
  • [35] Genomic characterization of IDH-mutant astrocytoma progression to grade 4 in the treatment setting
    Rautajoki, Kirsi
    Jaatinen, Serafiina
    Hartewig, Anja
    Tiihonen, Aliisa
    Annala, Matti
    Salonen, Iida
    Valkonen, Masi
    Simola, Vili
    Vuorinen, Elisa M.
    Kivinen, Anni
    Rauhala, Minna
    Nurminen, Riikka
    Maass, Kendra
    Lahtela, Sirpa-Liisa
    Jukkola, Arja
    Yli-Harja, Olli
    Helen, Pauli
    Pajtler, Kristian
    Ruusuvuori, Pekka
    Haapasalo, Joonas
    Zhang, Wei
    Haapasalo, Hannu
    Nykter, Matti
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2023, 11 (01)
  • [36] Histopathologic and Molecular Characterization of IDH-Mutant Prostatic Adenocarcinoma
    Samueli, Benzion
    Al-Ahmadie, Hikmat
    Chen, Ying-Bei
    Gopalan, Anuradha
    Sarungbam, Judy
    Sirintrapun, S. Joseph
    Tickoo, Satish
    Reuter, Victor
    Fine, Samson
    Chen, Jie-Fu
    LABORATORY INVESTIGATION, 2024, 104 (03) : S1050 - S1050
  • [37] Molecular, Histological, and Clinical Characteristics of Oligodendrogliomas: A Multi-Institutional Retrospective Study
    Dono, Antonio
    Alfaro-Munoz, Kristin
    Yan, Yuanqing
    Lopez-Garcia, Carlos A.
    Soomro, Zaid
    Williford, Garret
    Takayasu, Takeshi
    Robell, Lindsay
    Majd, Nazanin K.
    de Groot, John
    Esquenazi, Yoshua
    Kamiya-Matsuoka, Carlos
    Ballester, Leomar Y.
    NEUROSURGERY, 2022, 90 (05) : 515 - 522
  • [38] MOLECULAR, HISTOLOGIC AND CLINICAL CHARACTERISTICS OF OLIGODENDROGLIOMAS: A MULTI-INSTITUTIONAL RETROSPECTIVE STUDY
    Dono, Antonio
    Alfaro-Munoz, Kristin
    Yan, Yuanqing
    Lopez-Garcia, Carlos
    Soomro, Zaid
    Williford, Garret
    Takayasu, Takeshi
    Robell, Lindsay
    Majd, Nazanin
    de Groot, John
    Esquenazi, Yoshua
    Kamiya-Matsuoka, Carlos
    Ballester, Leomar Y.
    NEURO-ONCOLOGY, 2020, 22 : 168 - 168
  • [39] Molecular landscape of IDH-mutant astrocytoma and oligodendroglioma grade 2 indicate tumor purity as an underlying genomic factor
    Zhao, Binghao
    Xia, Yu
    Yang, Fengchun
    Wang, Yaning
    Wang, Yuekun
    Wang, Yadong
    Dai, Congxin
    Wang, Yu
    Ma, Wenbin
    MOLECULAR MEDICINE, 2022, 28 (01)
  • [40] Molecular landscape of IDH-mutant astrocytoma and oligodendroglioma grade 2 indicate tumor purity as an underlying genomic factor
    Binghao Zhao
    Yu Xia
    Fengchun Yang
    Yaning Wang
    Yuekun Wang
    Yadong Wang
    Congxin Dai
    Yu Wang
    Wenbin Ma
    Molecular Medicine, 2022, 28
12345